NASDAQ, UTHR - United Therapeutic
We are a biotechnology company focused on the development and
commercialization of unique products to address the unmet medical needs of
patients with chronic and life-threatening cardiovascular and infectious
diseases and cancer.
Our key therapeutic platforms are:
? ?
? Prostacyclin Analogs, which are stable synthetic forms of
prostacyclin, an important molecule produced by the body that has
powerful effects on blood vessel health and function. Our lead
prostacyclin analog is Remodulin?, a treprostinil-based compound for
the treatment of cardiovascular disease. Remodulin (treprostinil
sodium) Injection, has been approved by the U.S. ...
Read SEC Filing on NASDAQ.com »